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High-throughput techniques are needed to analyze individual virions to understand how viral hetero-
geneity translates into pathogenesis since in bulk analysis the individual characteristics of virions are
lost. Individual Dengue virions (DENV) undergo a maturation that involves a proteolytic cleavage of prM
precursor into virion-associated M protein. Here, using a new nanoparticle-based technology, “ﬂow
virometry”, we compared the maturation of individual DENV produced by BHK-21 and LoVo cells. The
latter lacks the furin-protease that mediates prM cleavage. We found that prM is present on about 50% of
DENV particles produced in BHK-21 cells and about 85% of DENV virions produced in LoVo, indicating an
increase in the fraction of not fully matured virions. Flow virometry allows us to quantify the number of
fully mature particles in DENV preparations and proves to be a useful method for studying heterogeneity
of the surface proteins of various viruses.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Viruses pursue different strategies in their infection of the host:
while some of them, for example hepatitis A, rely on the exact
reproduction of their antigenic spectra, others, like HIV are anti-
genically heterogeneous even when they are produced in homo-
geneous cell lines (Arakelyan et al., 2013) or the virus has been
cloned (Roederer et al., 2014). While the characterization of viral
preparations by most of the existing bulk techniques effectively
describes the composition and properties of an average virion in
the preparation, little is known about the variability between
virions. Since for enveloped viruses whose surface proteins med-
iate viral interactions with their cellular targets, this heterogeneity
may impact the biological properties of viruses. Recently, we
developed a new technique, “ﬂow virometry” that allows the
analysis of the antigenic composition of individual virions (Ara-
kelyan et al., 2013). In this study we focus on the surface protein
composition of individual DENV, an important human pathogen
(St John et al., 2013) that is well characterized structurally (Kuhn et
al., 2002; Mukhopadhyay et al., 2005).access article under the CC BY-NC
0, Rm.9D58, Bethesda, MD
ernomordik),DENV is a positive single-stranded RNA Flaviviridae. Its 11Kb
genome encodes a single large polyprotein, which is subsequently
cleaved into three structural and seven non-structural proteins
that are essential for viral replication. The structural proteins are
capsid (C), prM/membrane (prM/M) and envelope (E) (Lindenbach
and Rice, 2003). The E protein contains three distinct domains, the
structurally central domain DI, the dimerization domain DII, which
contains the fusion loop, and the immunoglobulin-like carboxy
terminal domain DIII involved in the attachment to host cell
receptors (Kielian and Rey, 2006).
DENV and the other ﬂaviviruses assemble in the ER as immature
viruses (Mukhopadhyay et al., 2005; Mackenzie and Westaway,
2001). The mildly acidic conditions of the trans-Golgi network
promote virus maturation, in which the E protein changes its con-
formation allowing the cleavage of prM into pr and M by a furin-like
protease (Murray et al., 1993; Randolph et al., 1990; Yu et al., 2008;
Zybert et al., 2008). The pr portion of prM covers the DII domain of
E, preventing premature viral fusion or inactivation in the acidic
intracellular compartments through which virions trafﬁc (Guir-
akhoo et al., 1992). Similarly to other viruses, an infectious DENV
preparation contains immature virions (Zhang et al., 2007). How-
ever, it remains to be understood whether there are any virions that
are fully matured, i.e., in which all prM molecules are cleaved, or all
the virions are either fully immature with all prM molecules in
uncleaved form or “mosaic”, with the same virions carrying both M-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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these proteins on the surface of single virions.
Towards this goal, here, we adapted a high throughput ﬂow
virometry technique (Arakelyan et al., 2013) to characterize the
degree of maturation of individual virions in a preparation of
infectious DENV. Brieﬂy, ﬂow virometry of DENV includes ﬁve
main steps: (i) labeling DENV with a ﬂuorescent lipidic dye DiI and
then with ﬂuorescent 2H2 antibodies that reveal prM protein; (ii)
capturing labeled virions with 15 nm-nanoparticles (MNPs) cou-
pled with 3H5-1 antibodies against E protein; (iii) separating the
DENV–MNPs complexes from unbound antibodies using magnetic
columns; (iv) eluting DENV–MNPs complexes from the columns,
and (v) analyzing the eluted complexes with a ﬂow cytometer. We
found that in DENV population produced by BHK-21 cells
approximately half of virions are fully mature as no prM could be
detected on their surface. In contrast, in DENV population pro-
duced in furin-deﬁcient LoVo cells, such a mature fraction con-
stitutes only 15%. The high throughput ﬂow virometry applied
here to DENV can be further used for the detailed characterization
of the heterogeneity of envelope proteins of various viruses and
may prove important in the development of vaccine against DENV.Results
For this ﬂow virometry study we deﬁned DENV as a membrane
particle that carries E protein. Therefore, to reveal DENV we ﬁrst
labeled our preparation with a ﬂuorescent lipidic dye DiI (adapted
from Zaitseva et al., 2010) and then stained virions for the presenceFig. 1. Analysis of individual virions. DiI-stained DENV preparation was serially diluted t
duplicate using a High Throughput Sampler (HTS) at a ﬂow rate of 0.5 μl per second on a
exclude aggregates. A singlet gate was deﬁned by plotting ﬂuorescence height versus ﬂu
represent aggregates. (B) Number of particles as a function of the dilution factor. DiI-la
evaluated by ﬂow cytometry based on volumetric control. Right panel is a blow up of the
serially diluted with a factor two and MFI was evaluated for each dilution. Note that the nu
constant in the large range of dilutions suggesting that the events correspond to single parof prM with ﬂuorescently labeled 2H2 anti-prM antibodies (Henchal
et al., 1982). To capture DiI ﬂuorescent particles that carry E protein
we used MNPs coupled with 3H5-1 antibodies (Gentry et al., 1982)
speciﬁc for the DIII domain of E protein. The DENV–MNPs complexes
were separated from free antibodies on magnetic columns: due to
the magnetic properties of MNPs these complexes were retained
while free antibodies were not. Preparations of DENV were analyzed
with a ﬂow cytometer triggered on viral ﬂuorescence.
Visualization of single particles
To verify that the events registered in ﬂow analysis represent single
virions rather than their aggregates, we ﬁrst analyzed in a ﬂow cyto-
meter free DiI-labeled DENV (Fig. 1) prepared as described inMethods.
In general, while the number of single particles measured by
ﬂow cytometry depends linearly on the dilution of the prepara-
tion, aggregates or coincident detection do not show a linear
relation with concentration (van der Pol et al., 2012). To distin-
guish between DENV aggregates and single virions, we diluted our
preparation in serial two-fold dilutions and evaluated the relation
between event frequencies and dilution factors. We excluded
aggregates from our analysis by the gating strategy presented in
Fig. 1A. Then we plotted the number of single events as a function
of the dilution factor (Fig. 1B). There is a linear relation between
the number of events and the dilution factor. Also, the mean
ﬂuorescence intensity (MFI) of events did not change over the four
orders of magnitude of the dilution series, and was on average
2679.6729 arbitrary ﬂuorescence units, with a coefﬁcient of
variation (CV) of 5.07% (Fig. 1C).wo fold from 1:2 to 1:2048. The events were acquired in a ﬁxed volume of 160 μl in
LSRII ﬂow cytometer, set to be triggered by DiI ﬂuorescence. (A) Gating strategy to
orescence width. This gate excludes events with a high width and high height that
beled virions were serially diluted and the number of events for each dilution was
left part of the X axis. (C) Median ﬂuorescence intensity (MFI). DiI-labeled DENV was
mber of events is inversely linearly dependent on the number of dilutions and the MFI is
ticles detection and not to swarm detection.
Fig. 2. Antibodies against DENV do not induce virus aggregation. DENV stock was labeled with DiI and treated or not with 2H2 antibodies or 3H5-1-MNPs. The viral
preparation was then serially diluted two fold to 1:256. (A) DiI labeled DENV. (B) DiI DENV stained with 2H2 Alexa Fluor 647 antibody. (C) DiI DENV-captured by 3H5-1 Alexa
Fluor 488 labeled MNPs. The events were acquired with HTS at a ﬂow rate of 0.5 μl per second on the LSRII ﬂow cytometer, set to be triggered by DiI ﬂuorescence. Single
particle detection. Two preparations of DENV, one stained with DiI (D) and the other with DIO (E). The two preparations were mixed and the virions were captured by 3H5-
1-MNPs and analyzed (F). Of the events recorded, approximately 10% appeared to be double positive. Thus, approximately 90% of events represent individual DENV virions.
Note that the number of events is inversely linearly dependent on the number of dilutions independently of the presence of the antibodies. Thus, the events correspond to single
particles and not to aggregates.
Fig. 3. Detection of DENV virions from BHK-21 and LoVo cells. Virions produced either by BHK-21or LoVo cells were incubated with Alexa Fluor 488 3H5-1- MNPs, separated
on magnetic columns and analyzed in a LSRII ﬂow cytometer using the same settings. (A) DiI-labeled DENV from BHK-21 captured by ﬂuorescent 3H5-1- MNPs. (B) DiI-
labeled DENV from LoVo cells captured by ﬂuorescent 3H5-1- MNPs. Presented is one typical experiment out of four. Note that in both preparations we capture with virus-
speciﬁc antibodies between 98 and 99% of DiI-labeled particles.
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ted events correspond predominantly to individual particles
(Nolan and Stoner, 2013). Since antibodies may cause viral aggre-
gation, we evaluated whether 2H2 Alexa Fluor 647 antibody or
3H5-1 Alexa Fluor 488 coupled MNPs cause aggregation. In both
cases, the number of events detected by ﬂow cytometry was
inversely linearly dependent on dilution factors indicating the lack
of a signiﬁcant aggregation under our protocol (Fig. 2A–C).Also to evaluate the level of aggregation we performed the
following experiment: we divided our preparation in two parts
and stained one with DiI and another with DiO, mixed these two
fractions and performed our standard capture experiment.
Aggregates, especially containing many particles, should be pre-
dominantly of two colors. This experiment (Fig. 2D–F) demon-
strated that more than 90% of the ﬂow events represent single
captured virions.
Fig. 4. Speciﬁcity of capture of DENV with 3H5-1-MNPs. DiI-stained DENV preparation was divided in two parts and virions in the ﬁrst half were captured via E protein with
Alexa Fluor 488 labeled 3H5-1-MNPs; virions in the second half of the preparation were incubated with non-speciﬁc Alexa Fluor 488-labeled Mouse IgG1-MNPs. Both
preparations were separated in magnetic ﬁeld and acquired using the same settings on LSRII ﬂow cytometer. (A) A bivariate plot of ﬂow analysis of virions. Speciﬁc DENV
capture (43000 events correspond to 98.5% of virions). (B) Non-speciﬁc capture. A typical experiment out of three. Note that non-speciﬁc MNPs capture less than 0.5% of the
virions captured with speciﬁc MNPs.
Fig. 5. Maturation state of DENV virions. DiI labeled DENV produced either in BHK-21 or in LoVo cells were stained for prM protein with Alexa Fluor 647-labeled 2H2 or with
its isotype control IgG2a, then captured with Alexa Fluor 488 3H5-1-MNPs (A) DENV produced in BHK-21 cells, stained with speciﬁc 2H2 antibody. (B) Isotype control to A.
(C) DENV produced in LoVo cells, stained with speciﬁc 2H2 antibody. (D) Isotype control to C. A representative experiment out of four. Note, a higher incidence of prM-positive
virions produced in furin-deﬁcient LoVo cells.
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We incubated 1107 puriﬁed DiI-stained particles with
6.41011 15 nm MNPs coupled with 3H5-1 antibodies labeled
with Zenon Alexa Fluor 488. The DENV–MNPs complexes were
separated from unbound viral particles and from unbound anti-
bodies on magnetic columns. We found that on average
98.3570.42% (n¼8) of all DiI-stained particles for BHK-21 and
97.3570.46% (n¼4) for LoVo were captured by 3H5-1 MNPs
labeled with Alexa Fluor 488 and therefore constitute bona ﬁde
DENV particles (Fig. 3). As control for the speciﬁcity of our capture,
we used 15 nm MNPs coupled with Mouse IgG labeled with Alexa
Fluor 488. We found that with these non-speciﬁc MNPs, we cap-
tured less than 0.5% of DENV that we captured with speciﬁc 3H5-
1-MNPs (Fig. 4) in similar conditions.
The efﬁciency of capture was evaluated also with real time PCR
(RT-PCR). While in the input preparation there where approxi-
mately 1107 DENV RNA copies/ml, in the ﬂow-through fraction
there were less than 4104 DENV RNA copies/ml, thus with our
method we capture more than 98% of viruses.
Characterization of virion maturity with ﬂow virometry
DENV virions in viral suspension were stained with DiI, incu-
bated with Alexa Fluor 647-labeled 2H2 anti-prM antibodies (and
their respective isotype controls) and captured with Zenon Alexa
Fluor 488-labeled 3H5-1-MNPs. DENV–MNPs complexes were
puriﬁed on magnetic column and analyzed with the ﬂow cyto-
meter. In the viral population produced by BHK-21 cells, on aver-
age 48.1675.35% (n¼8) of DENV virions (DiIþ/3H5-1þ) were
positive for the presence of prM as evaluated with the anti-prM
antibody (Fig. 5A). In viral population produced by LoVo cells, the
size of this fraction was larger with prM-positive virions repre-
senting 84.573.4% (n¼4) of all captured virions (Fig. 5C). The
difference between mature and immature particles produced by
BHK-21 and LoVo cells is signiﬁcant with p¼0.0005. Respectively
51.875.3% (n¼8) and 15.573.4% (n¼4) (p¼0.0005) of the cap-
tured DENV were prM negative and thus can be classiﬁed as fully
mature virions. The speciﬁcity of this staining protocol was con-
ﬁrmed by using isotype control antibodies (Fig. 5B and D).Discussion
DENV carries on its surface 180 copies of the envelope
(E) glycoprotein responsible for cell attachment and fusion to the
plasma membrane and 180 copies of the structural membrane
(M) protein (Zhang et al., 2003). Viral maturation involves the
cleavage of the prM precursor into M protein and pr peptide. In
this work we investigated the antigenic composition of individual
virions to reveal their maturation state by quantifying mature viral
particles (virions that do not carry prM) and not fully mature (or
completely immature) virions (carrying prM). Towards this goal
we used ﬂow virometry originally developed for the analysis of
individual HIV virions (Arakelyan et al., 2013) and extracellular
vesicles (EVs) (Arakelyan et al., 2015).
We collected DENV virions from supernatant of infected BHK-
21 and LoVo cells and labeled them with a ﬂuorescent lipidic dye
DiI. The latter was separated from stained particles in a dis-
continuous density gradient. As a result, we obtained a prepara-
tion of ﬂuorescent membrane particles released by DENV infected
cells. To identify DENV virions among other membrane particles,
we captured them with ﬂuorescently labeled Zenon Alexa Fluor
488 3H5-1-MNPs, speciﬁc for the E protein of DENV. Practically all
membrane particles isolated in our virus puriﬁcation protocol
based on Optiprep gradient carried E protein and thus, within ourdeﬁnition, represent DENV particles. In a direct ﬂow analysis of
this preparation it would be difﬁcult to distinguish virions from
antibodies (or their aggregates) by size or by ﬂuorescence making
it impossible to attribute any detected ﬂuorescent signal to labeled
viruses or to free ﬂoating antibodies occupying the cytometer
interrogation chamber. Therefore, it was critical to separate them
physically before the ﬂow analysis. Towards this goal, we run the
preparation in magnetic column. Such a separation removes free
antibody almost entirely (Arakelyan et al., 2015). Moreover, even if
a small amount of ﬂuorescent antibodies still contaminates the
ﬁnal preparation, it would not interfere with the analysis as DENV
are revealed by two labels, DiI envelope label and the label of the
capturing MNPs.
Next, we optimized the capture efﬁciency by testing various
MNPs to virions ratios. In agreement with the capture of HIV-1
(Arakelyan et al., 2013) we found that a ratio of MNP:DENV of
105 was optimal and at this ratio we capture about 98% of vir-
ions. The excess of MNPs was similar to the excess of ﬂuorescent
antibodies for staining cells. The efﬁciency of capture was con-
ﬁrmed by a real-time PCR assay: there was less than 0.5% of DENV
RNA in the “ﬂow through” fraction, demonstrating that all the
DENV genomes were captured.
After the development of the efﬁcient capture, we had to prove
that (i) this process was speciﬁc and, importantly, (ii) that we
monitored individual virions (otherwise our assay would be
another bulk analysis at which individual characteristics of virions
are lost).
The speciﬁcity of DENV capture was evident from the com-
parison of the number of complexes captured with MNPs coupled
to speciﬁc 3H5-1 antibodies with those captured with MNPs
coupled to non-speciﬁc isotype control antibodies.
Although the viral preparation was ﬁltered through 0.22 μm
ﬁlter, smaller aggregates could potentially contaminate our pre-
parations. To test that the ﬂow events correspond to single parti-
cles rather than to these aggregates, we investigated whether
there was a linear correlation between the dilution factor and the
number of events. We found a strong linear correlation between
the number of events and dilutions over the range of 2048 fold
dilutions. Also, the MFI of DENV DiI population did not change
over the four logs of the sample dilution series. These were two
criteria for the lack of aggregation (or swarms) of DENV in our
preparation (van der Pol et al., 2012; Nolan and Stoner, 2013).
However, if the aggregates were stable, their numbers upon
dilution would still follow a linear relation with the dilution factor.
Therefore, we performed additional experiments to evaluate
the number of aggregates in our captured preparation by mixing
DENV stained with two different colors and capturing their mix-
ture with anti-3H5-1 MNPs. We found that fewer than 10% of
events were multicolor aggregates. This data are in agreement
with the aggregation data of HIV (Arakelyan et al., 2013).
Staining with lipidic dyes alone would not distinguish viruses
from exosomes and impurities, additional staining is needed to
identify DENV particles. Here, we deﬁned a particle to be a DENV
virion if and only if it is stained by DiI and is positive for 3H5-1
antibodies against E protein (Fig. 3). Of course, microvesicles that
have captured viral proteins may also be included into our ana-
lysis. However such vesicles are essentially not different from
defective or non-infectious viruses.
In this work we stained DiI-labeled DENV for prM with 2H2
antibodies, captured themwith MNPs coupled to anti-E antibodies
3H5-1, and isolated MNP-captured stained virions in a magnetic
ﬁeld. 3H5-1 is maturation insensitive since it binds on the posi-
tions 383 – 385 of the DENV E protein, which is present on the
surface of all the viral particles independently of their maturation
state (Hiramatsu et al., 1996). In contrast, 2H2 is an antibody that
does not bind to mature M protein since it recognizes speciﬁcally
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with staining, we ﬁrst incubated virions with 2H2 antibodies and
then capture virions with 3H5-1 MNPs. Although a small reduction
in binding of 3H5-1 in presence of 2H2 was reported (Henchal
et al., 1985), with our protocol we captured around 98% of virions.
Finally, to test whether our technique revealed the state of
maturation of DENV we compared two DENV preparations: one
produced in BHK-1 cells and another in LoVo cells. The latter are
furin-deﬁcient and thus should produce more immature virions as
furin is required for prM cleavage and therefore for maturation
process (Stadler et al., 1997). Our analysis revealed that 55% of
the E-carrying virions produced in BHK-21 cells and 15% pro-
duced in LoVo cells do not carry detectable amount of prM. The
remaining 45% of DENV virions produced in BHK-21 and 85%
produced in LoVo cells carry prM and thus represent a mixture of
immature and partially mature (mosaic) virions. The existence of
mosaic ﬂaviviruses has been documented in earlier electron
microscopy studies that revealed co-existing smooth and spiky
elements on viral surface (Zhang et al., 2007; Junjhon et al., 2010).
These conclusions were based on experiments with prepara-
tions of DENV produced by different cell cultures. The number of
DENV positive for 2H2 in viral preparations produced by different
cell cultures varied more than that positive for 3H5-1. However, for
both antibodies the results were reproducible with CV 1% for
3H5-1, and 31.4% and 8% for 2H2 positive DENV produced
respectively by BHK-21 and LoVo cells.
Why do furin- deﬁcient cells still produce mature virions?
Since furin belongs to a family of the subtilisin-like serine endo-
proteases it is conceivable that different members of this family
overlap in their substrate speciﬁcities and intracellular localiza-
tions. Some proteases of this family including C5/PC6 and PC7/PC8
(both known, as furin, to reside in the trans-Golgi network) are
expressed in the furin-deﬁcient LoVo cells (Bolt and Pedersen,
1998). We hypothesize that these or other furin-like proteases are
responsible for a residual low efﬁciency cleavage of prM observed.
Although, in the case of DENV it is difﬁcult to evaluate the
absolute sensitivity of our measurements, in the case of HIV-1
with ﬂow virometry using similarly labeled antibodies against HIV
surface protein gp120 it was possible to reveal at least three of
these proteins.
While with our technology it is possible to evaluate the dif-
ference in maturity state of different preparations of virions, this
technology has several limitations. First, highly speciﬁc antibodies
against viral surface antigens are needed. Second, the antigens
should be accessible to the antibodies on the intact viral particles.
Third, different antibodies should not interfere with each other in
binding to the antigens. Future development may show other
limitations of this technology not revealed in the present study.
In summary, our analysis of antigens on individual virions
showed that our DENV preparation contains some fully mature
particles lacking prM and a larger fraction of prM-containing vir-
ions. Contributions of fully immature and mosaic virions to
infection are yet to be fully clariﬁed. Fully immature virions pro-
duced by furin-negative cells were reported to be completely non-
infectious (Zybert et al., 2008). However, anti-prM antibodies
(which facilitate viral attachment to the cell surface) facilitate
infection by fully immature DENV particles (Rodenhuis-Zybert
et al., 2010) and prM-containing virions have been found to
infect immature dendritic cells, probably through DC-SIGN (Rich-
ter et al., 2014). Future development of DENV ﬂow virometry may
reveal how many M proteins on an individual virion render it to be
infectious for particular cells.
Flow virometry earlier applied to the analysis of single HIV
virions and used here for analysis of single DENV virions seems to
be a universal method for analysis of heterogeneity of different
viruses that allows quantiﬁcation of virions carrying particularsurface proteins. Their physical separation will allow us to corre-
late the antigenic composition of virions with their biological
functions.Methods
Isolation of DENV 2 from supernatants of BHK-21 and LoVo cells
DENV 2 (New Guinea C strain) was purchased from ATCC
(Manassas, VA) and then produced in our laboratory in BHK-21
and LoVo cells at 80% of conﬂuence in T75 ﬂasks. These cells were
grown in 20 ml of DMEM supplemented with 10% FBS. For the
infection 0.01% of Pluronic F-127 (Invitrogen, Life Technologies,
Grand Island, NY) and 25 mM Tricine (Boston BioProducts, Ash-
land, MA) were added to the medium adjusted at pH 7.8 since
DENV is a pH dependent virus. The cells were washed with PBS
then inoculated with virus in 3 ml of medium at MOI of 0.5 and
the ﬂask was rocked to distribute the inoculum, followed by an
incubation for 10 min at room temperature to maximize viral
absorption. Then, 17 ml of medium were added to the ﬂask, which
was then incubated at 37 °C, 5% CO2, 80% relative humidity. After
2 days, the supernatants were collected and ﬁltered with a
0.22 μm syringe ﬁlter, pre-wetted with PBS 0.2% BSA. The obtained
viral stocks were kept at 4 °C (for not more than 3 months) and
used for ﬂow virometry.
Labeling with DiI and puriﬁcation of DENV 2 from supernatants of
BHK-21 and LoVo cells
For the labeling of DENV with the lipophilic tracer DiI (Invi-
trogen, Life Technologies), the viral preparations were incubated
with 0.01% Pluronic F-127 and 1 mM DiI in the dark for 30 min at
room temperature. For the Optiprep (Sigma, St. Louis, MO) dis-
continuous gradient, a 10 buffer was prepared with 20% NaCl
5 Mþ20% Tricine 1 M (pH 7.8)þ0.01% Pluronic F-127þ60% deio-
nized water. Then four gradient solutions, 10%, 20%, 25% and 35% of
Optiprep in deionized water were prepared using 10% buffer 10 .
The solutions were mixed and vortexed. After incubation, the
solutions were added in two 4 ml Seton open top tubes (Thermo
Scientiﬁc, Asheville, NC) to form a discontinuous gradient starting
from 35% to 10%. 1 ml of virus (108 viral particles/ml) with 10%
buffer 10 and 5% Optiprep solution was overlaid in each gradient
tube. The tubes were centrifuged at 240,000g for 1.5 h at 4 °C with
no brake. After centrifugation the DENV fraction between 20% and
25% Optiprep layers was recovered in an eppendorf tube. The
biggest viral aggregates were removed with a 0.22 μm ﬁlter
(Millipore, Waltham, MA) with centrifugation of 2000g for 5 min
at 4 °C. The viral particles were visualized on FACS as DiI positive
events thresholding on DiI ﬂuorescence.
Preparation of Alexa Fluor 647 2H2 detection antibody and its isotype
control
Labeling of monoclonal antibodies was performed according to
the Invitrogen protocol. 1 M solution of sodium bicarbonate at pH
8.3 was prepared by adding 1 ml of deionized water to 84 mg of
sodium bicarbonate powder. Then 10 ml of this solution were
added in a vial of 100 ml (1 mg/ml) of IgG2a 2H2 monoclonal
antibody (Millipore) against prM protein and mouse anti-human
IgG2a isotype control (Biolegend, San Diego, CA). Then 2H2 and its
isotype control were added in two different Alexa Fluor 647 car-
boxylic acid vials (Invitrogen, Life Technologies), mixed well and
incubated in rotation for 1 h at room temperature in the dark.
During the incubation two Zeba spin desalting columns (Thermo
Scientiﬁc) were washed with PBS two times to remove the storage
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Alexa Fluor 647-labeled antibodies were added to the column and
were centrifuged at 2000g for 3 min. The antibodies were recov-
ered in the ﬂow through and stored at 4 °C.
Next, we calculated the number of ﬂuorophores per antibody
molecule (the F:P, ﬂuorochrome/protein ratio) as described in the
Invitrogen Antibody Labeling Kit by measuring the absorbance of
the labeled antibodies on a Nanodrop 1000 (Thermo Scientiﬁc). On
average there were 6.5 ﬂuorophores of Alexa Fluor 647 per
molecule of 2H2.
Preparation of 3H5-1 15 nm MNPs
1 mg of 15 nm carboxyl-terminated magnetic iron oxide
nanoparticles (Ocean NanoTech, Springdale, AZ) was coupled to
IgG1 mouse monoclonal antibodies against DENV 2 (New Guinea
C) E protein (Millipore) following the Ocean Nanotech protocol for
conjugation. Brieﬂy, 200 μl of MNPs (1 mg) was aliquoted in an
eppendorf tube with 100 μl Activation Buffer and 100 μl EDAC/
NHS solution for 10 min at room temperature with continuous
mixing. After activation, 400 μl Coupling Buffer were added, mixed
well, and immediately followed by the addition of 1 mg of the
puriﬁed 3H5-1 antibody (Biovest International Inc., Minneapolis,
MN). After 2 h coupling with continuous mixing at room tem-
perature the reaction was stopped by adding 10 μl of Quenching
Buffer and transferred to a 1275 mm2 FACS tube. After an
overnight incubation in a SuperMAG-01 magnetic separator
(Ocean NanoTech) at 4 °C the MNPs were washed with Washing
Buffer and left again in SuperMAG-01 magnetic separator over-
night at 4 °C and another wash was performed the day after.
Finally, the 3H5-1 coupled MNPs were resuspended in 2 ml of
Storage Buffer and stored at 4 °C.
Titration of MNPs on DENV DiI particles
To optimize viral capture, we performed this procedure at
different MNP/virus ratios. We mixed 3.5105 viral particles, as
calculated based on real time PCR (RT-PCR) of viral genomes with
MNPs at concentrations ranging from 3.7105 to 3.71013 par-
ticles/ml in buffer (PBSþ2% mouse serumþ0.5% BSAþ2 mM
EDTA) followed by puriﬁcation of DENV–MNPs complexes on a
magnetic column. After two washes, the column was detached
from the magnet and the DENV–MNPs complexes were eluted,
analyzed, and quantiﬁed by ﬂow virometry using the DiI ﬂuores-
cence as a trigger parameter. To minimize the variability in sample
acquisition and to quantify the number of events in our prepara-
tion we acquired a ﬁxed volume (160 μl) of eluted samples in
duplicate using the High Throughput Sampler (HTS) at a ﬂow rate
of 0.5 μl per second on the LSRII ﬂow cytometer. This analysis
showed that the efﬁciency of capture dropped as a function of the
dilution of the MNPs. When the MNPs stock was diluted more
than 105 fold, which corresponds to a MNPs/DENV ratio o0.98,
DENV recovery dropped below 1% of the input virus. At higher
MNPs/DENV ratios, DENV recovery increased and was between
98% and 99% at a ratio of 9.8104. For all experiments described
hereafter we maintained this MNPs/DENV ratio.
Serial dilutions of the virus alone, with antibodies and with MNPs
Serial two-fold dilutions of the DENV DiI produced in BHK-21
cells were performed to show that the viral count by ﬂow cyto-
metry is inversely linearly dependent on the viral dilutions. The
serial dilutions were from 1:2 to 1:2048 folds. Samples were run
using a HTS at a ﬂow rate of 0.5 μl per second that was set to
acquire 160 μl of each sample using a LSRII ﬂow cytometer with a
threshold set at 600 ﬂuorescence units on the viral ﬂuorescencechannel. Next, to show that antibodies do not cause aggregation in
our system we treated or not DENV with 60 μl of 3H5-1-MNPs or
5 μg of 2H2 Alexa Fluor 647 antibodies and all viral preparations
were serially diluted two fold from 1:2 to 1:256. The events were
acquired with the same settings on HTS at a ﬂow rate of 0.5 μl
per second on the LSRII ﬂow cytometer, set to be triggered by DiI
ﬂuorescence.
Capture with MNPs and detection of DENV DiI produced in BHK-21
and LoVo cells
In order to visualize the 3H5-1MNPs complexes, 5 ml of a Zenon
Alexa Fluor 488 mouse IgG1 (Life Technologies) was added to the
mixture and incubated for 30 min at room temperature in con-
tinuous mixing. 1107 (60 ml) viral particles were incubated with
5 mg of Alexa Fluor 647 labeled 2H2 antibody against prM protein
and 1107 with 5 μg of Alexa Fluor 647 labeled IgG2a isotype
control for 30 min at room temperature. After 30 min the 3H5-1-
MNPs complexes were washed to remove free ﬂoating Zenon
Alexa Fluor 488 Fab fragments in 100K ﬁlters (Millipore). Then, in
the tubes with labeled virus with speciﬁc antibody and its isotype
control were added 9.61011 (60 ml) of 15 nm 3H5-1-MNPs. After
30 min of incubation at 37 °C with continuous mixing, the DENV–
MNPs complexes with bound antibodies were separated from
unbound reactants on MS MACS magnetic columns (Miltenyi
Biotech, Auburn, CA) mounted on a high ﬁeld MS MACS magnet
(Miltenyi Biotech). The columns were washed 3 times with the
washing buffer (PBSþ0.5% BSAþ1 mM EDTA) and the complexes
were eluted off the magnet in 400 μl of PBS and ﬁxed with 1%
paraformaldehyde in PBS. These puriﬁed complexes and their
corresponding ﬂow through fractions were analyzed with a LSRII
(BD Biosciences, San Jose, CA) ﬂow cytometer equipped with a
blue laser with a power of 200 mw and the blue ﬁlters are B515:
505DCLP 515/20; B660: 555DCLP 670/14; B710: 685LPXR 710/50
HQ. The violet laser (55 mw) has V-450: 450/50; V510: 505DCLP
521E; V-560: 555DCLP 560/40; V-605: 595DCLP 605/40; V-655:
635DCLP 655/20; V-690: 675 DCLP 695/40. The UV laser (25 mW)
UV-450: 450/50. The red laser (50 mW) R670: 675/20; R710:
690DCLP 710/40; R780: 735DCLP 780/60. The green laser
(150 mW) G585: 575/26; G610: 600LPXR 610/20; G675: 655DCLP
660/40 HQ; G695: 690LPXR 710/50 HQ; G800: 740LPXR 780/40
HQ. The voltages used to run our samples were FSC 288, SSC 205,
G585 500, B515 450, R670 520. The background level of ﬂuores-
cence was evaluated with 0.1 μm ﬁltered PBS and the threshold
was set up to the lowest ﬂuorescence channel that did not gen-
erate a G585 signal with this solution. Data were acquired using
Diva 6.3 and were analyzed with FlowJo software v9.4.9 (Treestar
Software, Ashland, OR). Using quantum MESF (Molecules of
Equivalent Soluble Fluorochrome) beads (Bangs Laboratories, Inc.,
Fishers, IN) and the manufacturer protocol, we evaluated the
threshold for the ﬂuorescent measurement for the setting of our
LSR II, which for Alexa Fluor 488 3H5-1 antibodies constituted 66
ﬂuorophores (approximatively 10 antibodies with a F:P ratio of
6.5–7.5).
Extraction and quantiﬁcation of DENV RNA by RT-PCR
A 200 μl aliquot of the MNPs complexes with DENV produced
in BHK-21 and LoVo cells and ﬂow through fractions was subjected
to nucleic acid extraction using a NucliSENS easyMAG 2.0 instru-
ment (BioMérieux, Durham, NC). RT-PCR was performed with a
qScript One-Step Fast MGB qRT-PCR kit (Quanta BioSciences, Gai-
thersburg, MD) using a one-step assay with the following primer
set: DENV 2 NGC (forward): TATGCTGAAACGCGAGAGAAA, DENV
2 NGC (reverse): CTGCAGCATTCCAAGTGAGA, and the probe: FAM-
CCG CGT GTC GAC TG TAC AAC AGC -MGB. Ampliﬁcations were
S. Zicari et al. / Virology 488 (2016) 20–27 27carried out on a BioRad CFX96 Touch Thermocycler according to
the following cycling parameters: 7.5 min at 48 °C, 30 s at 95 °C,
followed by 45 cycles of 3 s at 95 °C and 25 s at 60 °C.
Statistical analysis
Descriptive statistics were calculated with Excel. The results are
presented as means7standard errors of the mean (SEM), and n, the
number of replicates, is indicated. CV, the coefﬁcient of variation, was
calculated by expressing the standard deviation as % of the mean,
group comparisons were performed with the Student t test.Acknowledgments
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